Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

Metformin 6Pioglitazone 2Exercise 2ziprasidone 1salicylsalicylic acid 1licogliflozin 1exendin (9-39) 1drospirenone and ethinyl estradiol combination 1drospirenone 1cinnulin PF 1Vitamin D 1Sugars 1Sodium Salicylate 1Resistance Training 1Olanzapine 1Leuprolide 1Flutamide 1Ethinyl Estradiol 1Estrogens 1Diet Therapy 1Continuous Positive Airway Pressure 1Cholecalciferol 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Insulin Resistance × salicylsalicylic acid × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡